Latest AI and machine learning research in prostate cancer for healthcare professionals.
BACKGROUND: Long-term androgen deprivation therapy (LT-ADT) with radiotherapy is standard-of-care for high-risk localized prostate cancer, with abiraterone added for clinically very high-risk disease. Given the toxicity and cost of abiraterone, a predictive biomarker to refine patient selection is needed. We evaluated a digital pathology multimodal artificial intelligence (MMAI) model, previously ...
Targeting the intrinsically disordered N-terminal domain of the androgen receptor (AR-NTD) represents a promising strategy to overcome resistance in prostate cancer. However, its inherent lack of a stable tertiary structure and highly dynamic conformational ensemble pose formidable challenges for rational drug design. This study introduces an integrated computational workflow that combines enhance...
BACKGROUND: Early diagnosis of knee osteoarthritis (KOA) is often delayed due to reliance on subjective interpretation of radiographs. Recent advances...
Urinary extracellular vesicles (uEVs) are promising biomarkers for prostate cancer (PCa). Although novel uEV-based biomarkers have advanced early diag...
Effective waste classification is essential for improving resource recovery and reducing landfill burden. However, existing methods predominantly rely...
Prostate cancer (PCa) is the most common cancer in men. Treatment decisions for PCa consider factors like age, tumor stage, and grade, along with spec...
INTRODUCTION: Prostate cancer is well known to be androgen-dependent, with growth directly relying on the androgen receptor signaling pathway. In fact...
Prostate MRI is central to the diagnostic pathway for prostate cancer (PCa), reducing unnecessary biopsies, improving the detection of clinically sign...
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 annual meeting, held in Bogotá, Colombia, featured soapbox pr...
The efficient and unbiased isolation of small extracellular vesicles (sEVs) from complex biological fluids remains a major obstacle for clinical diagn...
OBJECTIVE: To assess the diagnostic performance of semen RNA-based biomarkers for detecting prostate cancer and differentiating cancer grade groups. M...
Patent ductus arteriosus (PDA) is a common congenital heart defect that requires timely and accurate detection to guide clinical management. Although ...
BACKGROUND: Micro-ultrasound (micro-US) is a clinically available novel high-resolution imaging technology for guiding prostate biopsies. However, cli...
BACKGROUND: Machine Learning (ML) models have achieved outstanding performance in predicting post-surgical survival. However, the "black-box" nature o...
The diagnosis of prostate cancer (PCa) is limited by the low specificity of prostate-specific antigen (PSA) testing, which contributes to overdiagnosi...
Steady state visual evoked potential (SSVEP)-based brain-computer interfaces have been widely studied for their fast response speeds and high informat...
In the event of a severe nuclear accident at a coastal nuclear power plant, the rapid and accurate assessment of radionuclide dispersion in surroundin...
BACKGROUND: Recognized worldwide as a major health threat and Sustainable Development Goal priority, breast cancer places an especially heavy clinical...
BACKGROUND: Prostate‑specific antigen (PSA) screening involves complex trade‑offs between early detection and the risks of overdiagnosis. For older ad...
Personalized treatment in psoriatic arthritis (PsA) remains challenging, particularly in guiding dose escalation decisions. We applied a causal machin...